Based on current trial populations and how the FDA has handled semaglutide and tirzepatide approvals, expected eligibility criteria are: BMI 30 , or BMI 27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, OSA) Adults 18 and older Not pregnant or breastfeeding No history of MTC or MEN 2 Retatrutide will almost certainly launch at a high price point estimates suggest $1,200$1,500 per month at list price
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Trzepacz P.T., McCue M., Klein I., Levey G.S., Greenhouse J
It mimics the effects of natural IGF-1 but is designed to be more potent and stay active in the body longer
ZpMeds weight loss program is here to help you transform your health, not just your waistline, with realistic goals, real science, and a lot of support
Key Fact: Foundayo's no-food-restrictions advantage makes it potentially ideal for shift workers, frequent travelers, and anyone who struggles with rigid morning routines